We found that T cells from BC patients have lower internalization capacity of central molecules of the TCR signaling machinery, namely CD3 and pZAP70, and demonstrate higher expression of exhaustion markers, such as TIM3 and LAG3. This evidence concerns the gene HAVCR2 and breast cancer.